ICU MEDICAL INC (ICUI) Fundamental Analysis & Valuation

NASDAQ:ICUI • US44930G1076

Current stock price

125.36 USD
-1.27 (-1%)
At close:
125.36 USD
0 (0%)
After Hours:

This ICUI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ICUI Profitability Analysis

1.1 Basic Checks

  • In the past year ICUI was profitable.
  • In the past year ICUI had a positive cash flow from operations.
  • In multiple years ICUI reported negative net income over the last 5 years.
  • ICUI had a positive operating cash flow in 4 of the past 5 years.
ICUI Yearly Net Income VS EBIT VS OCF VS FCFICUI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.02%, ICUI is in the better half of the industry, outperforming 71.20% of the companies in the same industry.
  • With a decent Return On Equity value of 0.03%, ICUI is doing good in the industry, outperforming 71.74% of the companies in the same industry.
  • The Return On Invested Capital of ICUI (2.43%) is better than 70.11% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ICUI is significantly below the industry average of 9.18%.
  • The last Return On Invested Capital (2.43%) for ICUI is above the 3 year average (1.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.02%
ROE 0.03%
ROIC 2.43%
ROA(3y)-1.15%
ROA(5y)0.08%
ROE(3y)-2.45%
ROE(5y)-0.91%
ROIC(3y)1.99%
ROIC(5y)2.63%
ICUI Yearly ROA, ROE, ROICICUI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

  • ICUI has a Profit Margin of 0.03%. This is in the better half of the industry: ICUI outperforms 71.74% of its industry peers.
  • ICUI's Profit Margin has declined in the last couple of years.
  • With a decent Operating Margin value of 4.90%, ICUI is doing good in the industry, outperforming 69.57% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ICUI has declined.
  • ICUI has a Gross Margin of 36.84%. This is in the lower half of the industry: ICUI underperforms 71.74% of its industry peers.
  • ICUI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.9%
PM (TTM) 0.03%
GM 36.84%
OM growth 3Y57.68%
OM growth 5Y-13.09%
PM growth 3YN/A
PM growth 5Y-65.63%
GM growth 3Y6.38%
GM growth 5Y0.29%
ICUI Yearly Profit, Operating, Gross MarginsICUI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ICUI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICUI is destroying value.
  • The number of shares outstanding for ICUI has been increased compared to 1 year ago.
  • The number of shares outstanding for ICUI has been increased compared to 5 years ago.
  • Compared to 1 year ago, ICUI has an improved debt to assets ratio.
ICUI Yearly Shares OutstandingICUI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
ICUI Yearly Total Debt VS Total AssetsICUI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • ICUI has an Altman-Z score of 2.06. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ICUI has a better Altman-Z score (2.06) than 61.41% of its industry peers.
  • The Debt to FCF ratio of ICUI is 15.58, which is on the high side as it means it would take ICUI, 15.58 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 15.58, ICUI is in the better half of the industry, outperforming 71.20% of the companies in the same industry.
  • A Debt/Equity ratio of 0.60 indicates that ICUI is somewhat dependend on debt financing.
  • ICUI has a Debt to Equity ratio of 0.60. This is in the lower half of the industry: ICUI underperforms 61.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 15.58
Altman-Z 2.06
ROIC/WACC0.25
WACC9.86%
ICUI Yearly LT Debt VS Equity VS FCFICUI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 2.39 indicates that ICUI has no problem at all paying its short term obligations.
  • ICUI's Current ratio of 2.39 is in line compared to the rest of the industry. ICUI outperforms 45.11% of its industry peers.
  • A Quick Ratio of 1.15 indicates that ICUI should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.15, ICUI is doing worse than 72.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.15
ICUI Yearly Current Assets VS Current LiabilitesICUI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ICUI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.76% over the past year.
  • ICUI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.71% yearly.
  • The Revenue has decreased by -6.33% in the past year.
  • Measured over the past years, ICUI shows a quite strong growth in Revenue. The Revenue has been growing by 11.91% on average per year.
EPS 1Y (TTM)24.76%
EPS 3Y5.87%
EPS 5Y1.71%
EPS Q2Q%-9.48%
Revenue 1Y (TTM)-6.33%
Revenue growth 3Y-0.72%
Revenue growth 5Y11.91%
Sales Q2Q%-13.78%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.23% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 4.49% on average over the next years.
EPS Next Y6.62%
EPS Next 2Y9.98%
EPS Next 3Y9.85%
EPS Next 5Y9.23%
Revenue Next Year-1.33%
Revenue Next 2Y1.52%
Revenue Next 3Y3.23%
Revenue Next 5Y4.49%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICUI Yearly Revenue VS EstimatesICUI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
ICUI Yearly EPS VS EstimatesICUI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. ICUI Valuation Analysis

4.1 Price/Earnings Ratio

  • ICUI is valuated correctly with a Price/Earnings ratio of 16.15.
  • 84.24% of the companies in the same industry are more expensive than ICUI, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of ICUI to the average of the S&P500 Index (25.23), we can say ICUI is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 15.15 indicates a correct valuation of ICUI.
  • Based on the Price/Forward Earnings ratio, ICUI is valued cheaply inside the industry as 84.78% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, ICUI is valued a bit cheaper.
Industry RankSector Rank
PE 16.15
Fwd PE 15.15
ICUI Price Earnings VS Forward Price EarningsICUI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ICUI is valued cheaper than 83.15% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICUI indicates a somewhat cheap valuation: ICUI is cheaper than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 37.37
EV/EBITDA 13.25
ICUI Per share dataICUI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.44
PEG (5Y)9.46
EPS Next 2Y9.98%
EPS Next 3Y9.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ICUI Dividend Analysis

5.1 Amount

  • No dividends for ICUI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICUI Fundamentals: All Metrics, Ratios and Statistics

ICU MEDICAL INC

NASDAQ:ICUI (3/20/2026, 8:00:42 PM)

After market: 125.36 0 (0%)

125.36

-1.27 (-1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-19
Earnings (Next)05-06
Inst Owners116.08%
Inst Owner Change-1.88%
Ins Owners0.96%
Ins Owner Change5.9%
Market Cap3.10B
Revenue(TTM)2.23B
Net Income(TTM)732.00K
Analysts83.33
Price Target187.27 (49.39%)
Short Float %4.7%
Short Ratio4.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.77%
Min EPS beat(2)10.68%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)29.63%
Min EPS beat(4)10.68%
Max EPS beat(4)38.85%
EPS beat(8)8
Avg EPS beat(8)31.35%
EPS beat(12)12
Avg EPS beat(12)27.15%
EPS beat(16)15
Avg EPS beat(16)20.28%
Revenue beat(2)1
Avg Revenue beat(2)0.72%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)2.43%
Revenue beat(4)2
Avg Revenue beat(4)0.69%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.09%
Revenue beat(8)5
Avg Revenue beat(8)0.8%
Revenue beat(12)6
Avg Revenue beat(12)-0.83%
Revenue beat(16)7
Avg Revenue beat(16)-0.86%
PT rev (1m)1.21%
PT rev (3m)1.21%
EPS NQ rev (1m)-1.51%
EPS NQ rev (3m)-1.51%
EPS NY rev (1m)0.87%
EPS NY rev (3m)0.87%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)1%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE 16.15
Fwd PE 15.15
P/S 1.39
P/FCF 37.37
P/OCF 17.21
P/B 1.46
P/tB N/A
EV/EBITDA 13.25
EPS(TTM)7.76
EY6.19%
EPS(NY)8.27
Fwd EY6.6%
FCF(TTM)3.35
FCFY2.68%
OCF(TTM)7.28
OCFY5.81%
SpS90.37
BVpS86.02
TBVpS-0.38
PEG (NY)2.44
PEG (5Y)9.46
Graham Number122.55
Profitability
Industry RankSector Rank
ROA 0.02%
ROE 0.03%
ROCE 3.08%
ROIC 2.43%
ROICexc 2.66%
ROICexgc 7.78%
OM 4.9%
PM (TTM) 0.03%
GM 36.84%
FCFM 3.71%
ROA(3y)-1.15%
ROA(5y)0.08%
ROE(3y)-2.45%
ROE(5y)-0.91%
ROIC(3y)1.99%
ROIC(5y)2.63%
ROICexc(3y)2.16%
ROICexc(5y)3.42%
ROICexgc(3y)6.21%
ROICexgc(5y)6.59%
ROCE(3y)2.51%
ROCE(5y)3.33%
ROICexgc growth 3Y68.14%
ROICexgc growth 5Y-6.18%
ROICexc growth 3Y65.14%
ROICexc growth 5Y-20.85%
OM growth 3Y57.68%
OM growth 5Y-13.09%
PM growth 3YN/A
PM growth 5Y-65.63%
GM growth 3Y6.38%
GM growth 5Y0.29%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 15.58
Debt/EBITDA 4.09
Cap/Depr 48.33%
Cap/Sales 4.35%
Interest Coverage 1.31
Cash Conversion 58%
Profit Quality 11315.8%
Current Ratio 2.39
Quick Ratio 1.15
Altman-Z 2.06
F-Score6
WACC9.86%
ROIC/WACC0.25
Cap/Depr(3y)43.46%
Cap/Depr(5y)52.62%
Cap/Sales(3y)4.09%
Cap/Sales(5y)4.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.76%
EPS 3Y5.87%
EPS 5Y1.71%
EPS Q2Q%-9.48%
EPS Next Y6.62%
EPS Next 2Y9.98%
EPS Next 3Y9.85%
EPS Next 5Y9.23%
Revenue 1Y (TTM)-6.33%
Revenue growth 3Y-0.72%
Revenue growth 5Y11.91%
Sales Q2Q%-13.78%
Revenue Next Year-1.33%
Revenue Next 2Y1.52%
Revenue Next 3Y3.23%
Revenue Next 5Y4.49%
EBIT growth 1Y6.35%
EBIT growth 3Y56.54%
EBIT growth 5Y-2.74%
EBIT Next Year28.75%
EBIT Next 3Y15.51%
EBIT Next 5Y12.24%
FCF growth 1Y-27.23%
FCF growth 3YN/A
FCF growth 5Y-7.51%
OCF growth 1Y-11.85%
OCF growth 3YN/A
OCF growth 5Y-4.19%

ICU MEDICAL INC / ICUI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ICUI.


Can you provide the valuation status for ICU MEDICAL INC?

ChartMill assigns a valuation rating of 5 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.


What is the profitability of ICUI stock?

ICU MEDICAL INC (ICUI) has a profitability rating of 5 / 10.


Can you provide the financial health for ICUI stock?

The financial health rating of ICU MEDICAL INC (ICUI) is 4 / 10.


What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?

The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 6.62% in the next year.